Yahoo Finance • 19 hours ago

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fir... Full story

Yahoo Finance • 8 days ago

Progyny signals $200M share repurchase and targets $1.278B 2025 revenue while expanding supplemental fertility plans

Earnings Call Insights: Progyny, Inc. (PGNY) Q3 2025 MANAGEMENT VIEW * CEO Peter Anevski highlighted a strong quarter, stating "Progyny had a very strong third quarter with revenue and profitability that exceeded the high end of our gu... Full story

Yahoo Finance • 8 days ago

Progyny, Inc. Announces Third Quarter 2025 Results

Reports Revenue of $313.3 Million, Reflecting 9.3% Growth Raises Full Year Guidance to Reflect Continued Strength in Member Engagement Selling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing Base... Full story

Yahoo Finance • 23 days ago

Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs for global employe... Full story

Yahoo Finance • 28 days ago

Progyny seesaws amid confusion over impact from Trump’s IVF initiative

[Down is Up. Up is Down.] Kenneth Cheung/iStock via Getty Images Shares of fertility benefits provider Progyny (NASDAQ:PGNY [https://seekingalpha.com/symbol/PGNY]) turned volatile as the Trump administration announced a new initiative to... Full story

Yahoo Finance • last month

Progyny CEO Named World Economic Forum Champion for Women’s Health

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a Champion for Wome... Full story

Yahoo Finance • 3 months ago

Canaccord Genuity raises Progyny stock price target to $23 on stable outlook

Investing.com - Canaccord Genuity raised its price target on Progyny (NASDAQ:PGNY) to $23.00 from $21.00 on Wednesday, while maintaining a Hold rating on the fertility benefits management company. According to InvestingPro data, the stock... Full story

Yahoo Finance • 3 months ago

Progyny Inc (NASDAQ:PGNY) – A Prime Affordable Growth Stock with Strong Fundamentals and Fair Valuation

Investors looking for growth opportunities at fair prices often consider the "Affordable Growth" strategy, which focuses on companies with strong growth potential and reasonable valuations. This method selects stocks with a growth rating a... Full story

Yahoo Finance • 3 months ago

Earnings call transcript: Progyny Q2 2025 beats EPS forecasts with strong growth

Progyny Inc (PGNY) reported its second-quarter 2025 earnings, surpassing analysts’ expectations with an adjusted earnings per share (EPS) of $0.48, significantly higher than the forecasted $0.16. The company also achieved a revenue of $332... Full story

Yahoo Finance • 3 months ago

Progyny raises full-year 2025 revenue guidance to $1.27B as member engagement and product expansion accelerate

Earnings Call Insights: Progyny (PGNY) Q2 2025 MANAGEMENT VIEW * CEO Peter Anevski reported "a strong second quarter with good growth in both revenue and adjusted EBITDA over the prior year, resulting in record quarterly results across... Full story

Yahoo Finance • 3 months ago

Progyny, Inc. Announces Second Quarter 2025 Results

Reports Record Revenue of $332.9 Million, Reflecting 9.5% Growth Generates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in P... Full story

Yahoo Finance • 3 months ago

PROGYNY INC (NASDAQ:PGNY) Stands Out as a High-Quality Buy-and-Hold Stock with Strong Growth and Financial Health

The Caviar Cruise stock screening strategy is built to find high-quality companies ideal for long-term, buy-and-hold investing. Based on the ideas of quality investing, the screen focuses on businesses with steady revenue and profit growth... Full story

Yahoo Finance • 4 months ago

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new partnership with ŌURA, maker of the world’s leading smart ring, further empo... Full story

Yahoo Finance • 4 months ago

Leerink Partners upgrades Progyny stock rating to Outperform on improved membership activity

Investing.com - Leerink Partners upgraded Progyny (NASDAQ:PGNY) from Market Perform to Outperform on Tuesday, maintaining a price target of $28.00, which represents approximately 9x CY26 EV/EBITDA. The company, which maintains a "GREAT" fi... Full story

Yahoo Finance • 4 months ago

Progyny stock rises as BofA reiterates Buy rating on better-than-expected Q2

Investing.com - Progyny (NASDAQ:PGNY) stock rose after BofA Securities maintained its Buy rating and $30.00 price target on the fertility benefits management company. According to InvestingPro data, the company maintains a "GREAT" financia... Full story

Yahoo Finance • 4 months ago

Progyny Reveals $200 Mln Revolving Credit Facility, Sees Q2 Results Slightly Ahead Of Expectations

(RTTNews) - Progyny, Inc. (PGNY), a company focused on women's health and family-building solutions, said on Tuesday that it has entered into a revolving credit facility of up to $200 million until its maturity on July 1, 2030. Pete Anevs... Full story

Yahoo Finance • 4 months ago

Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report

Operational and Financial Flexibility Enhanced Through New Credit Facility Second Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq... Full story

Yahoo Finance • 5 months ago

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that it is adding pelvic floor therapy to its comprehensive offering of women’s he... Full story

Yahoo Finance • 5 months ago

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new collaboration with Amazon’s Health Benefits Connector to expand access to co... Full story

Yahoo Finance • 6 months ago

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors.... Full story